These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6678470)

  • 1. Pelvic lymphadenectomy is essential to staging accuracy in most patients with stages A-2 and B prostate cancer before radical prostatectomy.
    Catalona WJ
    Semin Urol; 1983 Aug; 1(3):212-6. PubMed ID: 6678470
    [No Abstract]   [Full Text] [Related]  

  • 2. Pelvic lymphadenectomy is not essential to staging accuracy in all patients with localized prostate cancer.
    Paulson DF
    Semin Urol; 1983 Aug; 1(3):204-11. PubMed ID: 6678469
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment on: Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.
    Oyama N
    Eur Urol; 2007 Aug; 52(2):429. PubMed ID: 17397993
    [No Abstract]   [Full Text] [Related]  

  • 4. Radical prostatectomy for localized prostate cancer.
    Middleton RG
    Semin Urol; 1983 Aug; 1(3):229-35. PubMed ID: 6678471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer.
    Middleton RG
    NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: the predictors of pelvic lymph node metastasis at radical retropubic prostatectomy.
    Liedberg F
    J Urol; 2004 Oct; 172(4 Pt 1):1545-6. PubMed ID: 15371890
    [No Abstract]   [Full Text] [Related]  

  • 8. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
    Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
    Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of pelvic lymph-node status in prostatic cancer].
    Schubert J; Heidl G; Nitzsche H; Wehnert J; Moravek P
    Z Urol Nephrol; 1983 Dec; 76(12):763-70. PubMed ID: 6199912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic biopsy undergrading: the feasibility of secondary laparoscopic pelvic lymphadenectomy.
    Hellawell G; Ramírez-Backhaus M; Rabenalt R; Do M; Dietel A; Stolzenburg JU
    Urol Int; 2010; 85(2):139-42. PubMed ID: 20516675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
    AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and management of isolated lymph node recurrence in patients with PSA relapse.
    Schöder H; Bochner B
    Eur Urol; 2007 Aug; 52(2):310-2. PubMed ID: 17376587
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens.
    Association of Clinical Pathologists
    J Clin Pathol; 2008 Jun; 61(6):713-21. PubMed ID: 18326012
    [No Abstract]   [Full Text] [Related]  

  • 17. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
    Heidenreich A; Pfister D; Thüer D; Brehmer B
    BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse].
    Osmonov DK; Aksenov AV; Jünemann KP
    Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.